RNS Number : 0095M Stifel Nicolaus Europe Limited 25 April 2024   FORM 8.5 (EPT/RI)   PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the "Code")   1.         KEY INFORMATION   (a) Name

RNS Number : 8535L Stifel Nicolaus Europe Limited 24 April 2024   FORM 8.5 (EPT/RI)   PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the "Code")   1.         KEY INFORMATION   (a) Name

RNS Number : 6659L Stifel Nicolaus Europe Limited 23 April 2024   FORM 8.5 (EPT/RI)   PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the "Code")   1.         KEY INFORMATION   (a) Name

RNS Number : 5771L Renalytix PLC 22 April 2024   Renalytix plc ("Renalytix" or the "Company")   Issue of Shares and Rule 2.9 Announcement   LONDON and SALT LAKE CITY -   22 April 2024   - Further to the announcements on 8 April 2024 and 15 April 2024 ,   Renalytix plc   (NASDAQ: RNLX) (LSE: RENX)  

RNS Number : 5653L Renalytix PLC 22 April 2024     Renalytix plc ("Renalytix" or the "Company")   Result of General Meeting   LONDON and SALT LAKE CITY , 22 April 2024   -   Renalytix plc   (NASDAQ: RNLX) (LSE: RENX) announces that at the General Meeting (" GM ") held earlier today all resolutions

RNS Number : 4959L Stifel Nicolaus Europe Limited 22 April 2024   FORM 8.5 (EPT/RI)   PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the "Code")   1.         KEY INFORMATION   (a) Name

RNS Number : 0516L Renalytix PLC 18 April 2024     Renalytix plc ("Renalytix" or the "Company")   Renalytix Announces Management Change - Howard Doran Promoted to President   LONDON and SALT LAKE CITY , 18 April 2024   -   Renalytix plc   (NASDAQ: RNLX) (LSE: RENX) announces that Howard Doran , who

RNS Number : 8404K Renalytix PLC 16 April 2024       Renalytix plc ("Renalytix" or the "Company")   Rule 2.9 Announcement   LONDON  and  SALT LAKE CITY , 16 April 2024  -  Renalytix plc  (NASDAQ: RNLX) (LSE: RENX), i n accordance with Rule 2.9 of the City Code on Takeovers and Mergers (" Takeover

RNS Number : 7824K Stifel Nicolaus Europe Limited 16 April 2024   FORM 8.5 (EPT/RI)   PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the "Code")   1.         KEY INFORMATION   (a) Name

RNS Number : 6814K Renalytix PLC 15 April 2024   TR-1: S tandard form for notification of major holdings   NOTIFICATION OF MAJOR HOLDINGS   (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) i 1a. Identity of the issuer or the underlying issuer of existing